Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Sequential ctDNA profiling in advanced ovarian cancer

Interventional study of serial circulating tumor DNA in suspected advanced ovarian cancer. The registry lists the phase as not applicable and the primary outcome as the ability of ctDNA to detect recurrence. ClinicalTrials.gov lists the study as recruiting.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS